Navigating tuberculosis drug discovery with target-based screening

Author： Miller Christopher H O'Toole Ronan F

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.8, 2011-08, pp. : 839-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening

By Lapan Kirsty A Chapple Joanne P Galcheva-Gargova Zoya Yang Min Tao Jianshi

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 507-516

Informa Healthcare

Access to resources Recommend Favorite

Target-Based Drug Discovery for Malaria, Leishmaniasis, and Trypanosomiasis

Current Medicinal Chemistry, Vol. 7, Iss. 8, 2000-08 ,pp. : 835-860

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on the Network Models in Target-based Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 18, Iss. 13, 2018-05 ,pp. : 1031-1043

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-01 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

FtsZ: A Novel Target for Tuberculosis Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 527-543

Bentham Science Publishers

Access to resources Recommend Favorite